Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting now
Conditions studied: HIV/AIDS, Pregnancy Related, Congenital Disorders, Newborn Morbidity
In brief
The purpose of this study is to develop a pharmacovigilance (PV) surveillance program to monitor adverse pregnancy and infant outcomes, including the presence of congenital abnormalities, among HIV-positive and HIV-negative women and their infants at clinical sites affiliated with the International Epidemiology Databases to Evaluate consortium (IeDEA).
Key facts
- Study ID
- NCT04405700
- Run by
- Indiana University
- People needed
- 2800
- Starts
- 2020-09-29
- Expected to finish
- 2026-05-31
- Last updated by the study team
- 2025-08-19
Who can join
Age: any. Sex: female. Healthy volunteers: accepted.
Where it is running
- Moi Teaching and Referral Hospital — Eldoret, Kenya (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.